Cytori Therapeutics Inc (NASDAQ:CYTX) announced the presentation of six and twelve month data from the ATHENA Trials at the annual meeting of The Society …
Cytori Therapeutics Inc (NASDAQ:CYTX) presented preclinical data at the Annual Meeting of the American Burn Association (ABA) in Las Vegas showing the potential …
Recent developments in biotech stocks Cytori Therapeutics Inc (NASDAQ:CYTX) and StemCells Inc (NASDAQ:STEM) attract analysts’ attention as pipeline treatments inch toward the end of their final testing …
Healthcare analysts from Mizuho and Maxim weigh in on pharma giant Allergan plc Ordinary Shares (NYSE:AGN) and cell therapy firm Cytori Therapeutics Inc (NASDAQ:CYTX), following …
Cytori Therapeutics Inc (NASDAQ:CYTX) announced the top-line data as part of the pre-specified partial unblinding of 24 week follow up data from the …
Cytori Therapeutics Inc (NASDAQ:CYTX) announced that its U.S.
Cytori Therapeutics Inc (NASDAQ:CYTX) announced today that its licensee Kerastem Technologies, LLC, has expanded STYLE, its US phase II clinical trial investigating early …
Cytori Therapeutics Inc (NASDAQ:CYTX) announced enrollment of the first two patients in an investigator-initiated clinical trial of Cytori Cell Therapy™ for the treatment of …
Cytori Therapeutics Inc (NASDAQ:CYTX) announced today that it has entered into an agreement with Idis Managed Access, part of the Clinigen Group plc, …
Analysts are weighing in on the biopharmaceutical companies Cytori Therapeutics Inc (NASDAQ:CYTX) and Osiris Therapeutics, Inc. (NASDAQ:OSIR), as shares of both companies fell …